Cards Row (3) - White
Personal Fundraiser FAQs-
-
-
Hello Label my old friend
Now we have a longer description
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Cards Row (2) - Light
Personal Fundraiser FAQs-
-
Hello Label my old friend
Now we have a longer description
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Cards Row (2) - Light
Personal Fundraiser FAQs-
-
Hello Label my old friend
Now we have a longer description
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
CTA Block - Light
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
CTA Block - Light
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
CTA Block - Light
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Donate - white
Lorem ipsum
Flipcards - White
Our DEI Commitment
Heading text
Heading text
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Card Heading
Card Heading
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
The heading of the card
The heading of the card
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Flipcards - Light
Our DEI Commitment
Heading text
Heading text
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Card Heading
Card Heading
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
The heading of the card
The heading of the card
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Flipcards - Dark
Our DEI Commitment
Heading text
Heading text
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Card Heading
Card Heading
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
The heading of the card
The heading of the card
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Image Carousel (BG = dark)
Description text
Image Carousel (BG = dark)
Description text
Image Carousel (BG = dark)
Description text
People Cards (3) (images Yes) - Light
-
Carolyn Zainer
Founder and Owner of CAZ Designs, Inc
-
David Sturges
Co-Founder & Treasurer Emeritus, Lung Cancer Foundation of America
-
David Carbone, MD, PhD
Professor of Medicine in the Division of Medical Oncology, The Ohio State University – James Cancer Hospital and Solove Research Institute
-
Dr. David H. Johnson, MD
Emeritus
Donald W. Seldin Distinguished Chair in Internal Medicine at UT Southwestern Medical Center in Dallas, Texas
Chairman of the Department of Internal Medicine at UT Southwestern Medical Center in Dallas, Texas
People Cards (3) (images Yes) - Light
-
Carolyn Zainer
Founder and Owner of CAZ Designs, Inc
-
David Sturges
Co-Founder & Treasurer Emeritus, Lung Cancer Foundation of America
-
David Carbone, MD, PhD
Professor of Medicine in the Division of Medical Oncology, The Ohio State University – James Cancer Hospital and Solove Research Institute
-
Dr. David H. Johnson, MD
Emeritus
Donald W. Seldin Distinguished Chair in Internal Medicine at UT Southwestern Medical Center in Dallas, Texas
Chairman of the Department of Internal Medicine at UT Southwestern Medical Center in Dallas, Texas
-
Donna Whitney
Director of Digital Strategy & Web
-
David T. Levinson
Founder/Executive Director – Big Sunday
People Cards (3) (images Yes) - Light
-
Carolyn Zainer
Founder and Owner of CAZ Designs, Inc
-
David Sturges
Co-Founder & Treasurer Emeritus, Lung Cancer Foundation of America
-
David Carbone, MD, PhD
Professor of Medicine in the Division of Medical Oncology, The Ohio State University – James Cancer Hospital and Solove Research Institute
-
Dr. David H. Johnson, MD
Emeritus
Donald W. Seldin Distinguished Chair in Internal Medicine at UT Southwestern Medical Center in Dallas, Texas
Chairman of the Department of Internal Medicine at UT Southwestern Medical Center in Dallas, Texas
-
Donna Whitney
Director of Digital Strategy & Web
-
David T. Levinson
Founder/Executive Director – Big Sunday
Researcher Cards
Homepage-
Julie Wu, MD
Staff Physician, Medical Oncology
Precision oncology integrating evidence-based models into clinical practice to personalize treatment approaches
-
Aparna Sharma, DM
Thoracic medical oncologist
Genomic characterization of young onset lung adenocarcinoma
-
Jonathan Villena-Vargas, MD
Thoracic Surgeon
Characterizing T cell PD-1 response in the tumor-draining lymph nodes of early-stage NSCLC patients
-
Jarushka Naidoo, MRCPI
Clinical/Translational Investigator
Identifying novel biomarkers of response and toxicity to immunotherapy
Researcher Cards
Homepage-
Julie Wu, MD
Staff Physician, Medical Oncology
Precision oncology integrating evidence-based models into clinical practice to personalize treatment approaches
-
Aparna Sharma, DM
Thoracic medical oncologist
Genomic characterization of young onset lung adenocarcinoma
-
Jonathan Villena-Vargas, MD
Thoracic Surgeon
Characterizing T cell PD-1 response in the tumor-draining lymph nodes of early-stage NSCLC patients
-
Jarushka Naidoo, MRCPI
Clinical/Translational Investigator
Identifying novel biomarkers of response and toxicity to immunotherapy
-
Researcher Cards
Homepage-
Julie Wu, MD
Staff Physician, Medical Oncology
Precision oncology integrating evidence-based models into clinical practice to personalize treatment approaches
-
Aparna Sharma, DM
Thoracic medical oncologist
Genomic characterization of young onset lung adenocarcinoma
-
Jonathan Villena-Vargas, MD
Thoracic Surgeon
Characterizing T cell PD-1 response in the tumor-draining lymph nodes of early-stage NSCLC patients
-
Jarushka Naidoo, MRCPI
Clinical/Translational Investigator
Identifying novel biomarkers of response and toxicity to immunotherapy
-
-
Jon Zugazagoitia, MD, PhD
Thoracic Oncology
Developing precision immunotherapy strategies to improve outcomes of patients with NSCLC
-
Jacob Kaufman, Md, PhD
Medical Oncology
Understanding how the specific genetic background of each cancer affects their behaviors in patients
Label Text
Stats Columns (3) - White
34 Thingamabobs
$749M For research
7 Reasons to donate
Label Text
Stats Columns (3) - Light
34 Thingamabobs
$749M For research
7 Reasons to donate
Label Text
Stats Columns (6) - White
34 Thingamabobs
$749M For research
7 Reasons to donate
4Q To a gallon
12 Eggs in a carton
5,280 Feet in a mile
Timeline Block
Lorem ipsum
Treatment Cards - White
-
Chemotherapy
Chemotherapy uses pills, medicines injected in your veins, or both to shrink or kill cancers. This treatment may be used alone or with radiation before or after surgery. Prepare for chemotherapy by learning what to expect. -
Radiation
Radiation therapy uses high-energy rays (similar to X-rays) to destroy cancer cells. The type of radiation therapy most often used to treat SCLC is called external beam radiation therapy (EBRT). Techniques include: Three-dimensional conformal radiation therapy (3D-CRT), Intensity modulated radiation therapy (IMRT), and Stereotactic body radiation therapy (SBRT). -
Surgery
Surgery might be an option for early-stage non-small cell lung cancer (NSCLC). It typically provides the best chance to cure the disease at this stage.
Lorem ipsum
Treatment Cards - Light
-
Chemotherapy
Chemotherapy uses pills, medicines injected in your veins, or both to shrink or kill cancers. This treatment may be used alone or with radiation before or after surgery. Prepare for chemotherapy by learning what to expect. -
Radiation
Radiation therapy uses high-energy rays (similar to X-rays) to destroy cancer cells. The type of radiation therapy most often used to treat SCLC is called external beam radiation therapy (EBRT). Techniques include: Three-dimensional conformal radiation therapy (3D-CRT), Intensity modulated radiation therapy (IMRT), and Stereotactic body radiation therapy (SBRT). -
Surgery
Surgery might be an option for early-stage non-small cell lung cancer (NSCLC). It typically provides the best chance to cure the disease at this stage.
Lorem ipsum
Treatment Cards - Dark
-
Chemotherapy
Chemotherapy uses pills, medicines injected in your veins, or both to shrink or kill cancers. This treatment may be used alone or with radiation before or after surgery. Prepare for chemotherapy by learning what to expect. -
Radiation
Radiation therapy uses high-energy rays (similar to X-rays) to destroy cancer cells. The type of radiation therapy most often used to treat SCLC is called external beam radiation therapy (EBRT). Techniques include: Three-dimensional conformal radiation therapy (3D-CRT), Intensity modulated radiation therapy (IMRT), and Stereotactic body radiation therapy (SBRT). -
Surgery
Surgery might be an option for early-stage non-small cell lung cancer (NSCLC). It typically provides the best chance to cure the disease at this stage.
Video row caption
Optional Kicker
Video Row (dark bg)
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Video row caption
Optional Kicker
Video Row (dark bg)
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Video row caption
Optional Kicker
Video Row (dark bg)
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Word of the Day
Phase IV clinical trial
The fourth stage of testing a new treatment or therapy after it has been approved and is available for public use. Phase IV trials gather additional information about long-term safety and effectiveness.
Word of the Day
Phase IV clinical trial
The fourth stage of testing a new treatment or therapy after it has been approved and is available for public use. Phase IV trials gather additional information about long-term safety and effectiveness.
Word of the Day
Phase IV clinical trial
The fourth stage of testing a new treatment or therapy after it has been approved and is available for public use. Phase IV trials gather additional information about long-term safety and effectiveness.